Natures Sunshine Products Stock Discussion

The company's underlying earnings potential is seen as equal or superior to the statutory profit. High cash conversion is reflected in its unusual items. Assuming these don't recur, Nature's Sunshine Products is expected to yield a higher profit next year.

Nature's Sunshine's revenue growth rate of 5% over the last three years is considered weak for a consumer staples business. The company's free cash flow margin has averaged 2.7%, which is subpar for a consumer staples business, but it has seen year-on-year increases of 8.5 percentage points over the last 12 months.

Despite challenges, personal care stocks sector showed resilience with average share prices up 20.3%. Nature's Sunshine and Olaplex outperformed, while Nu Skin, USANA, and BeautyHealth underperformed.